What is the CPT code for a lesion scrape or swab for Varicella-Zoster Virus DNA detection via PCR in an immunocompromised patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CPT Code for Varicella-Zoster Virus Lesion Testing

For a lesion scrape or swab for Varicella-Zoster Virus (VZV) DNA detection via PCR in an immunocompromised patient, the appropriate CPT code is 87798 (Infectious agent detection by nucleic acid [DNA or RNA], not otherwise specified; amplified probe technique, each organism).

Specimen Collection and Testing Approach

Optimal Specimen Types for VZV Detection

  • Vesicular or macular/papular lesion specimens are the gold standard for VZV diagnosis, with PCR sensitivity of 95-100% when collected at rash onset 1
  • Lesion swabs or scrapes should be obtained from the base of fresh vesicles or early macular/papular lesions for maximum viral DNA yield 1, 2
  • In immunocompromised patients specifically, VZV DNA detection rates in skin lesions approach 100% during active infection 3

Alternative Specimen Considerations

  • Oral/throat swabs can be considered as supplementary specimens, particularly in immunocompromised patients where VZV DNA was detected in 60% of throat swabs within two weeks of rash onset 4
  • However, oral swab sensitivity (74.2%) is significantly lower than skin lesion specimens and should not replace dermal sampling 2
  • Blood specimens (whole blood, plasma, or serum) show detection rates of 81-100% in immunocompromised patients with herpes zoster, emphasizing the risk of disseminated disease in this population 3

Clinical Context for Immunocompromised Patients

Diagnostic Urgency

  • Laboratory confirmation is specifically needed for immunocompromised patients with atypical clinical presentations, as clinical diagnosis alone should not be relied upon in this population 5
  • PCR testing of vesicle fluid is the gold standard with nearly 100% sensitivity and specificity 5
  • Treatment should be initiated immediately upon clinical suspicion without waiting for laboratory confirmation 5

Timing of Specimen Collection

  • Specimens should be collected as early as possible after rash onset for optimal diagnostic yield 1
  • Viral shedding peaks in the first 24 hours after lesion onset when most lesions are vesicular 6
  • In immunocompromised patients, lesions may continue to develop over 7-14 days, providing a longer window for specimen collection compared to immunocompetent hosts 6

Additional CPT Codes to Consider

  • 87252 may be used for direct fluorescent antibody (DFA) testing of skin lesions, though this has lower sensitivity than PCR 7
  • 87798 remains the most appropriate code for VZV PCR from any specimen type (lesion, oral, blood)
  • If multiple specimen types are tested simultaneously (e.g., lesion swab plus blood), each PCR test would be coded separately with 87798

Common Pitfalls to Avoid

  • Do not rely on serologic testing (IgM/IgG) for acute diagnosis, as serology is not useful for diagnosing active shingles 5
  • Avoid collecting specimens after lesions have completely crusted, as viral DNA yield decreases significantly 1
  • Do not use oral swabs as the sole specimen type for breakthrough varicella diagnosis, as sensitivity is inadequate 2

References

Research

Evaluation of laboratory methods for diagnosis of varicella.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010

Guideline

Herpes Zoster Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.